Vyteris, a drug delivery technology provider, will merge with MediSync BioServices Inc., a privately held company focused on the consolidation of CROs, SMOs and related businesses. MediSync’s current and planned services include product development, clinical trial management, and data management services for the pharmaceutical, biotechnology and medical device industries. MediSync was formed in 2006 by a group of life sciences executives, and its growth efforts are, according to a compa...